Furthermore, if Lilly does not pull its ads voluntarily in the coming days, Novo said it will seek a preliminary injunction to immediately block them. Novo Nordisks lawsuit comes as its once dominating position in the GLP-1 market that it launched has eroded, with CNBC reporting earlier this year that Novos market share had dwindled to about 40%, with Lilly at 60% market share
In the study trials published in June 2024, people with OSA who received 10 mg or 15 mg tirzepatide had improved sleep quality (fewer breath holding episodes) and improved measurements of daytime sleepiness
Sejaro, 10 mg/dose, solution for subcutaneous injection Each mL of the solution contains 16.67 mg of tirzepatide
Most providers will reassure you that a single accidental intramuscular injection is not harmful
A clinician will look at side effects and the amount of weight youre losing and work with you to determine whether a higher dose will be safe and effective for you
Frequency depends on individual goals and medical evaluation